HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NCCIH Director Briggs Leaving: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

NCCIH Director Josephine Briggs will depart the center after nine years, with deputy director David Shurtleff serving as acting director; the 10th Circuit will not rehear MusclePharm's complaint against insurer; blood sugar supplement firm receives FDA warning letter; more news in brief.

You may also be interested in...

MusclePharm Tangles With Insurer For Costs From SEC Investigation

MusclePharm maintains Liberty Insurance Underwriters breached its policy and should reimburse $3m the firm spent defending SEC charges of accounting and disclosure violations. The insurer argues it was not responsible for the period during which the SEC conducted its investigation.

Interview: NCCIH Director Josephine Briggs On The Science Supporting More Self-Care

In an interview with “The Tan Sheet,” Briggs discusses topics including the lack of data on drug-supplement interactions and NCCIH’s interest in funding research on standards for assessing the clinical importance of those interactions.

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts